Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Starý J, Schlegelberger B, Niemeyer CM, Flotho C. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica 2010; 95(2):320-323; https://doi.org/10.3324/haematol.2009.010355.